S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
Log in
NYSE:CMD

Cantel Medical Stock Forecast, Price & News

$79.98
+2.35 (+3.03 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$77.35
Now: $79.98
$80.18
50-Day Range
$76.17
MA: $79.12
$84.66
52-Week Range
$20.81
Now: $79.98
$89.10
Volume808,231 shs
Average Volume768,876 shs
Market Capitalization$3.38 billion
P/E Ratio95.22
Dividend YieldN/A
Beta1.54
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Cantel Medical logo

MarketRank

Overall MarketRank

1.26 out of 5 stars

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone973-890-7220
Employees3,669

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.02 billion
Cash Flow$3.52 per share
Book Value$17.31 per share

Profitability

Net Income$13.71 million

Miscellaneous

Market Cap$3.38 billion
Next Earnings Date3/4/2021 (Estimated)
OptionableOptionable
$79.98
+2.35 (+3.03 %)
(As of 01/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cantel Medical (NYSE:CMD) Frequently Asked Questions

How has Cantel Medical's stock been impacted by Coronavirus (COVID-19)?

Cantel Medical's stock was trading at $49.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CMD shares have increased by 60.9% and is now trading at $79.98.
View which stocks have been most impacted by COVID-19
.

Is Cantel Medical a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cantel Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMD, but not buy additional shares or sell existing shares.
View analyst ratings for Cantel Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cantel Medical?

Wall Street analysts have given Cantel Medical a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cantel Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cantel Medical's next earnings date?

Cantel Medical is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Cantel Medical
.

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) issued its earnings results on Tuesday, December, 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.54. The firm had revenue of $297.03 million for the quarter, compared to the consensus estimate of $292.50 million. Cantel Medical had a net margin of 3.38% and a return on equity of 11.19%.
View Cantel Medical's earnings history
.

What guidance has Cantel Medical issued on next quarter's earnings?

Cantel Medical issued an update on its first quarter 2021 Pre-Market earnings guidance on Thursday, October, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $290-295 million, compared to the consensus revenue estimate of $256.2 million.

What price target have analysts set for CMD?

4 brokers have issued 1 year price targets for Cantel Medical's shares. Their forecasts range from $51.00 to $100.00. On average, they anticipate Cantel Medical's stock price to reach $71.50 in the next year. This suggests that the stock has a possible downside of 10.6%.
View analysts' price targets for Cantel Medical
or view Wall Street analyst' top-rated stocks.

Who are some of Cantel Medical's key competitors?

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include Gilead Sciences (GILD), JPMorgan Chase & Co. (JPM), Medtronic (MDT), NVIDIA (NVDA), Cisco Systems (CSCO), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC) and Citigroup (C).

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the following people:
  • Mr. Charles Michael Diker, Chairman & Member of Office of the Chairman (Age 85, Pay $373.47k)
  • Mr. George L. Fotiades, CEO, Vice Chairman & Member of Office of the Chairman (Age 66, Pay $667.67k)
  • Mr. Peter G. Clifford, Pres & COO (Age 50, Pay $560.62k)
  • Mr. Shaun M. Blakeman, Sr. VP, CFO & Member of Office of the Chairman (Age 42, Pay $404.63k)
  • Mr. Jeffrey Z. Mann, Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 48, Pay $369.12k)
  • Mr. Seth M. Yellin, Exec. VP & Chief Growth Officer (Age 46, Pay $424.38k)
  • Mr. Brian R. Capone, Sr. VP, Corp. Controller & Chief Accounting Officer (Age 45)
  • Mr. Michael Drexel, CTO & Sr. VP
  • Mr. Matthew Micowski, VP of Corp. FP&A and Investor Relations
  • Ms. Milicent Brooks, Head of Corp. Communications

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

Who are Cantel Medical's major shareholders?

Cantel Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (1.58%), Scout Investments Inc. (0.25%), State of Alaska Department of Revenue (0.01%), Sheets Smith Wealth Management (0.01%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Cantel Medical stock include Anthony B Evnin, Brian Capone, Charles M Diker, George L Fotiades, Jeffrey Z Mann, Lawrence Conway, Mark N Diker and Ronnie Myers.
View institutional ownership trends for Cantel Medical
.

Which institutional investors are selling Cantel Medical stock?

CMD stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for Cantel Medical
or view top insider-selling stocks.

Which institutional investors are buying Cantel Medical stock?

CMD stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Crossmark Global Holdings Inc., Scout Investments Inc., and Sheets Smith Wealth Management. Company insiders that have bought Cantel Medical stock in the last two years include Anthony B Evnin, George L Fotiades, Jeffrey Z Mann, and Mark N Diker.
View insider buying and selling activity for Cantel Medical
or or view top insider-buying stocks.

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $79.98.

How big of a company is Cantel Medical?

Cantel Medical has a market capitalization of $3.38 billion and generates $1.02 billion in revenue each year. The company earns $13.71 million in net income (profit) each year or $1.65 on an earnings per share basis. Cantel Medical employs 3,669 workers across the globe.

What is Cantel Medical's official website?

The official website for Cantel Medical is www.cantelmedical.com.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.